"Human papillomavirus 16" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of ALPHAPAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.
Descriptor ID |
D052162
|
MeSH Number(s) |
B04.280.210.655.050.616 B04.613.204.655.050.616
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Human papillomavirus 16".
Below are MeSH descriptors whose meaning is more specific than "Human papillomavirus 16".
This graph shows the total number of publications written about "Human papillomavirus 16" by people in this website by year, and whether "Human papillomavirus 16" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2015 | 3 | 2 | 5 |
2017 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human papillomavirus 16" by people in Profiles.
-
Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res. 2022 02; 10(2):259-271.
-
HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout. Virology. 2021 02; 554:9-16.
-
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer. J Immunother Cancer. 2019 09 18; 7(1):252.
-
The Role of DCT in HPV16 Infection of HaCaTs. PLoS One. 2017; 12(1):e0170158.
-
A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16. J Virol. 2015 Sep; 89(17):9103-14.
-
Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol. 2015 Aug; 51(8):727-30.
-
HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head Neck. 2016 Jan; 38(1):59-65.
-
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol. 2015 Feb; 125(2):330-337.
-
HPV-negative head and neck squamous cell carcinomas: how can we use the tumor protein signature? Biomark Med. 2015; 9(3):183-5.
-
Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol. 2014 Jun; 88(12):6751-61.